Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Officials are waiting for test results from a few preliminary, potential H5N1 cases over the last day or so in Central and ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Newsweek has contacted Moderna and the HHS via email outside of regular office hours. Avian influenza A (H5N1) has caused at least 67 human illnesses, and was associated with one death ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

The award will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza, Moderna said on Friday. “Avian flu variants have proven to be particularly ...